Janssen Pharmaceutical Appoints Cherry Huang as CEO for Korea and Greater China

According to Korean media reports on the 25th, Janssen Pharmaceuticals has announced the appointment of Cherry Huang as Chief Executive Officer of Janssen Pharmaceuticals Korea, with concurrent oversight of operations in Hong Kong, Macao and Taiwan, China, effective June 1.

It is reported that upon graduating in 1997, Cherry Huang joined Johnson & Johnson as a Financial Analyst. From 2011 to 2015, she served as the Head of Finance at Xian Janssen, and subsequently held the positions of Senior Finance Director for Johnson & Johnson’s Southeast Asia region and Chief Financial Officer of Janssen Pharmaceuticals, Asia-Pacific.